Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pathophysiological mechanisms leading to muscle loss in chronic kidney disease
Xiaonan H. Wang, William E. Mitch, S. Russ Price
Nature Reviews Nephrology (2021) Vol. 18, Iss. 3, pp. 138-152
Closed Access | Times Cited: 101

Showing 1-25 of 101 citing articles:

Association between sarcopenia and clinical outcomes in chronic kidney disease patients: A systematic review and meta-analysis
Heitor S. Ribeiro, Silvia Gonçalves Ricci Neri, Juliana S Oliveira, et al.
Clinical Nutrition (2022) Vol. 41, Iss. 5, pp. 1131-1140
Closed Access | Times Cited: 91
Prevalence of sarcopenia in patients with chronic kidney disease: a global systematic review and meta‐analysis
Marvery P. Duarte, Lucas S. Almeida, Silvia Gonçalves Ricci Neri, et al.
Journal of Cachexia Sarcopenia and Muscle (2024) Vol. 15, Iss. 2, pp. 501-512
Open Access | Times Cited: 58
The impact of senescence on muscle wasting in chronic kidney disease
Ying Huang, Bin Wang, Faten Hassounah, et al.
Journal of Cachexia Sarcopenia and Muscle (2022) Vol. 14, Iss. 1, pp. 126-141
Open Access | Times Cited: 48
Nrf2 Activation in Chronic Kidney Disease: Promises and Pitfalls
Ana Karina Aranda‐Rivera, Alfredo Cruz‐Gregorio, José Pedraza‐Chaverrí, et al.
Antioxidants (2022) Vol. 11, Iss. 6, pp. 1112-1112
Open Access | Times Cited: 42
Muscle mass and estimates of renal function: a longitudinal cohort study
Dion Groothof, Adrian Post, Harmke A. Polinder‐Bos, et al.
Journal of Cachexia Sarcopenia and Muscle (2022) Vol. 13, Iss. 4, pp. 2031-2043
Open Access | Times Cited: 41
Muscle fat infiltration in chronic kidney disease: a marker related to muscle quality, muscle strength and sarcopenia
Carla María Avesani, Aline Miroski de Abreu, Heitor S. Ribeiro, et al.
Journal of Nephrology (2023) Vol. 36, Iss. 3, pp. 895-910
Open Access | Times Cited: 40
Exercise during Hemodialysis in Patients with Chronic Kidney Failure
Kirsten Anding‐Rost, Gero von Gersdorff, Pia von Korn, et al.
NEJM Evidence (2023) Vol. 2, Iss. 9
Closed Access | Times Cited: 40
Cytoprotective remedies for ameliorating nephrotoxicity induced by renal oxidative stress
Ranmali Ranasinghe, Michael L. Mathai, Anthony Zulli
Life Sciences (2023) Vol. 318, pp. 121466-121466
Open Access | Times Cited: 31
Saikosaponin A and D attenuate skeletal muscle atrophy in chronic kidney disease by reducing oxidative stress through activation of PI3K/AKT/Nrf2 pathway
Minna Huang, Yan Yan, Zihao Deng, et al.
Phytomedicine (2023) Vol. 114, pp. 154766-154766
Open Access | Times Cited: 26
Frailty in patients on dialysis
Gordon Chun‐Kau Chan, Kamyar Kalantar‐Zadeh, Jack Kit‐Chung Ng, et al.
Kidney International (2024) Vol. 106, Iss. 1, pp. 35-49
Open Access | Times Cited: 13
Caffeic acid alleviates skeletal muscle atrophy in 5/6 nephrectomy rats through the TLR4/MYD88/NF-kB pathway
Jinyue He, Zhuoen He, Hao Wang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 174, pp. 116556-116556
Open Access | Times Cited: 11
Skeletal Muscle Injury in Chronic Kidney Disease—From Histologic Changes to Molecular Mechanisms and to Novel Therapies
Kylie Heitman, Matthew S. Alexander, Christian Faul
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 10, pp. 5117-5117
Open Access | Times Cited: 9
The role of lean body mass in predicting mortality in hemodialysis patients across different age groups
Jieun Kim, Jinyeong Yi, Jae Ho Kim, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Personalized Nutrition in Chronic Kidney Disease
Nishigandha Pradhan, Jennifer K. Kerner, Luciana Aparecida Campos, et al.
Biomedicines (2025) Vol. 13, Iss. 3, pp. 647-647
Open Access | Times Cited: 1
Combating chronic kidney disease-associated cachexia: A literature review of recent therapeutic approaches
Yalda Rahbar Saadat, Amin Abbasi, Seyyed Sina Hejazian, et al.
BMC Nephrology (2025) Vol. 26, Iss. 1
Open Access | Times Cited: 1
Muscle Wasting in Chronic Kidney Disease: Mechanism and Clinical Implications—A Narrative Review
Tsai-Chin Cheng, Shou-Hsien Huang, Chung‐Lan Kao, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 11, pp. 6047-6047
Open Access | Times Cited: 31
Lobetyolin Alleviates Ferroptosis of Skeletal Muscle in 5/6 Nephrectomized Mice via Activation of Hedgehog-GLI1 Signaling
Shi-Hao Ni, Xiaojiao Zhang, Xiao-Lu Ou-Yang, et al.
Phytomedicine (2023) Vol. 115, pp. 154807-154807
Closed Access | Times Cited: 17
Creatinine, cystatin C, muscle mass, and mortality: Findings from a primary and replication population‐based cohort
Dion Groothof, Naser B.N. Shehab, Nicole S. Erler, et al.
Journal of Cachexia Sarcopenia and Muscle (2024) Vol. 15, Iss. 4, pp. 1528-1538
Open Access | Times Cited: 7
Association between sarcopenia and new-onset chronic kidney disease among middle-aged and elder adults: findings from the China Health and Retirement Longitudinal Study
Ying Liu, Yang Wu, Xirong Cao, et al.
BMC Geriatrics (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 6
Exercise for patients with chronic kidney disease: from cells to systems to function
Jared M. Gollie, Alice S. Ryan, Sabyasachi Sen, et al.
AJP Renal Physiology (2024) Vol. 326, Iss. 3, pp. F420-F437
Closed Access | Times Cited: 5
Biomarkers of chronic kidney disease in older individuals: navigating complexity in diagnosis
Lucia Muglia, Michele Di Dio, Elvira Filicetti, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 5
Activation of the Aryl Hydrocarbon Receptor in Muscle Exacerbates Ischemic Pathology in Chronic Kidney Disease
Nicholas P. Balestrieri, Victoria Palzkill, Caroline Pass, et al.
Circulation Research (2023) Vol. 133, Iss. 2, pp. 158-176
Open Access | Times Cited: 13
High prevalence of sarcopenia and myosteatosis in patients undergoing hemodialysis
Chen Fu, Dong Yan, Ling Wang, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 11
Impairments of functional exercise capacity, muscle strength, balance and kinesiophobia in patients with chronic kidney disease: a cross-sectional study
Nihan Katayıfçı, İrem Hüzmeli̇, Döndü İri̇ş, et al.
BMC Nephrology (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 4
The gut microbiome, chronic kidney disease, and sarcopenia
Guilang Zheng, Jingyuan Cao, Xiaonan H. Wang, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top